NCT07105267View on ClinicalTrials.gov

Open Label Phase IIa Trial Evaluating the Effect and Safety of Transplantation of Fecal Microbiota in Children With Autism Spectrum Disorders and Gastrointestinal Symptoms

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

April 1, 2027

Study Completion Date

April 1, 2027

Conditions
Autism Spectrum DisorderFecal Microbiota Transplantation (FMT)
Interventions
DRUG

FMT Protocol

FMT protocol Samples (urine, blood, stool) collection Psychological examination Pediatric quality of life Scale Bristol Stool form Scale

Trial Locations (1)

75019

Robert Debré Hospital, Paris

All Listed Sponsors
collaborator

Fondation initiative autisme

UNKNOWN

collaborator

Fondation Erie

UNKNOWN

collaborator

Biocodex microbiota fondation

UNKNOWN

lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT07105267 - Open Label Phase IIa Trial Evaluating the Effect and Safety of Transplantation of Fecal Microbiota in Children With Autism Spectrum Disorders and Gastrointestinal Symptoms | Biotech Hunter | Biotech Hunter